Name | Number of supported studies | Average coverage | |
---|---|---|---|
squamous epithelial cell | 4 studies | 50% ± 23% | |
astrocyte | 4 studies | 27% ± 4% |
Insufficient scRNA-seq data for expression of A2ML1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 41% | 45626.64 | 596 / 1445 | 62% | 101.69 | 113 / 183 |
tonsil | 0% | 0 | 0 / 0 | 93% | 162.88 | 42 / 45 |
skin | 72% | 12265.65 | 1300 / 1809 | 14% | 4.71 | 64 / 472 |
uterus | 2% | 1001.70 | 3 / 170 | 55% | 48.52 | 252 / 459 |
brain | 2% | 28.31 | 66 / 2642 | 52% | 3.96 | 370 / 705 |
bladder | 5% | 55.05 | 1 / 21 | 43% | 19.47 | 216 / 504 |
lung | 0% | 0 | 0 / 578 | 34% | 17.44 | 394 / 1155 |
pancreas | 0% | 5.53 | 1 / 328 | 26% | 8.38 | 47 / 178 |
breast | 0% | 4.82 | 2 / 459 | 19% | 6.86 | 211 / 1118 |
ovary | 1% | 8.71 | 1 / 180 | 14% | 1.60 | 62 / 430 |
intestine | 0% | 2.81 | 2 / 966 | 6% | 9.10 | 34 / 527 |
prostate | 1% | 14.78 | 2 / 245 | 6% | 0.43 | 28 / 502 |
stomach | 1% | 193.00 | 3 / 359 | 5% | 0.57 | 14 / 286 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.25 | 1 / 29 |
adrenal gland | 0% | 0 | 0 / 258 | 3% | 0.13 | 6 / 230 |
thymus | 0% | 5.88 | 1 / 653 | 1% | 0.11 | 5 / 605 |
adipose | 0% | 27.17 | 6 / 1204 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.06 | 4 / 901 |
muscle | 0% | 23.37 | 3 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 4.90 | 4 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.28 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0052548 | Biological process | regulation of endopeptidase activity |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0030414 | Molecular function | peptidase inhibitor activity |
Gene name | A2ML1 |
Protein name | Alpha-2-macroglobulin-like protein 1 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9) Alpha-2-macroglobulin like 1 |
Synonyms | CPAMD9 |
Description | FUNCTION: Is able to inhibit all four classes of proteinases by a unique 'trapping' mechanism. This protein has a peptide stretch, called the 'bait region' which contains specific cleavage sites for different proteinases. When a proteinase cleaves the bait region, a conformational change is induced in the protein which traps the proteinase. The entrapped enzyme remains active against low molecular weight substrates (activity against high molecular weight substrates is greatly reduced). Following cleavage in the bait region a thioester bond is hydrolyzed and mediates the covalent binding of the protein to the proteinase (By similarity). Displays inhibitory activity against chymotrypsin, papain, thermolysin, subtilisin A and, to a lesser extent, elastase but not trypsin. May play an important role during desquamation by inhibiting extracellular proteases. . |
Accessions | ENST00000299698.12 [A8K2U0-1] F5GYG7 H0YGG5 ENST00000545692.1 F5GXP1 ENST00000539547.5 [A8K2U0-2] H0YH14 ENST00000537475.1 A8K2U0 ENST00000541459.5 ENST00000536789.5 |